Canada· CA-DIN-02244673

TRILEPTAL ORAL SUSPENSION

A oxcarbazepine product containing oxcarbazepine, registered in Canada by NOVARTIS PHARMACEUTICALS CANADA INC. The same ATC class is registered in 15 of our 19 countries.

ATC N03AF02

Checked against Health Canada Drug Product Database (Canada) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxcarbazepineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxcarbazepine is registered in 15 of 19 countries.

Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.

This record: Canada, from Health Canada Drug Product Database (Canada)
9 of them publish a price we can compare per daily dose

Search oxcarbazepine products by name

Oxcarbazepine · ATC N03AF02

15 / 19 countries

Belgiumprice
Canada
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxcarbazepine costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Oxcarbazepine · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$2.54
FR France$1.08
IT Italy$0.73
US United States$0.56 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

Health Canada Drug Product Database (Canada)

Active substance: OXCARBAZEPINE
Manufacturer: NOVARTIS PHARMACEUTICALS CANADA INC
Country: Canada (CA)
ATC code: N03AF02
ATC class: Oxcarbazepine
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: Health Canada Drug Product Database (Canada)
Last checked: October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

398 interactions on record for oxcarbazepine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxcarbazepine against other medicines How interaction checks work

Oxcarbazepine · interactions on record

398 records

8 severe
263 moderate
7 minor
72 info

Most severe, free to view

Levonorgestrel and ethinylestradiolG03AA07severe
Desogestrel and ethinylestradiolG03AA09severe
Drospirenone and ethinylestradiolG03AA12severe
EthinylestradiolG03CA01severe

48 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxcarbazepine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxcarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Trileptal
Belgium · Oxcarbazepine Viatris, Trileptal
Bulgaria · Трилептал
Cyprus · Oxcarbazepine Jubilant, Trileptal
Germany · Apydan Extent, Oxcarbazepin 1 A Pharma
Denmark · Apydan, Oxcarbazepin Jubilant
Estonia · Apydan, Trileptal
Spain · Oxcarbazepina Cinfa, Oxcarbazepina Normon
Finland · Apydan, Oxcarbazepin Orion
France · Oxcarbazepine Sandoz, Oxcarbazepine Viatris
United Kingdom (Northern Ireland) · Oxcarbazepine, Oxcarbazepine Amarox
Greece · Trileptal
Croatia · Trileptal
Hungary · Trileptal
Ireland · Trileptal
Iceland · Oxcarbazepine Jubilant, Trileptal
Italy · Oxcarbazepina Tecnigen, Tolep
Lithuania · Trileptal
Latvia · Trileptal
Netherlands · Oxcarbazepine Adoh, Oxcarbazepine Jubilant
Norway · Trileptal
Poland · Karbagen, Oxepilax
Portugal · Epilfarmo, Oxcarbazepina Biofarmoz
Romania · Trileptal
Sweden · Trileptal
Slovenia · Karbox
Slovakia · Trileptal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e87a104e-8d11-49ed-9ce8-bbfb6528ec22
GET /v1/drugs/e87a104e-8d11-49ed-9ce8-bbfb6528ec22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02244673",
  "form": "SUSPENSION",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "N03AF02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "68661",
  "strengths": [
    "60 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "OXCARBAZEPINE"
  ],
  "product_categorization": null
}

API reference MCP server Plans

See everything about oxcarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console